Morgan Stanley Merus N.V. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Merus N.V. stock. As of the latest transaction made, Morgan Stanley holds 1,349,819 shares of MRUS stock, worth $56.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,349,819

Previous 1,501,650 10.11%

Holding current value

$56.5 Million

Previous $88.9 Million 24.1%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$47.19 - $58.84 $7.16 Million - $8.93 Million	-151,831 Reduced 10.11%	1,349,819 $67.4 Million
Q2 2024 Oct 17, 2024	BUY	$39.81 - $60.2 $20.9 Million - $31.5 Million	523,795 Added 53.57%	1,501,650 $88.9 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $20.9 Million - $31.5 Million	523,795 Added 53.57%	1,501,650 $88.9 Million
Q1 2024 Oct 17, 2024	SELL	$28.03 - $51.82 $14.7 Million - $27.1 Million	-523,795 Reduced 34.88%	977,855 $44 Million
Q1 2024 Aug 16, 2024	BUY	$28.03 - $51.82 $15.7 Million - $29.1 Million	561,314 Added 134.76%	977,855 $44 Million
Q1 2024 May 15, 2024	BUY	$28.03 - $51.82 $15.7 Million - $29.1 Million	561,314 Added 134.76%	977,855 $44 Million
Q4 2023 Aug 16, 2024	SELL	$20.06 - $28.66 $21.8 Million - $31.1 Million	-1,085,109 Reduced 72.26%	416,541 $11.5 Million
Q4 2023 Feb 13, 2024	BUY	$20.06 - $28.66 $1.4 Million - $2 Million	69,645 Added 20.08%	416,541 $11.5 Million
Q3 2023 Nov 15, 2023	SELL	$20.13 - $27.29 $984,216 - $1.33 Million	-48,893 Reduced 12.35%	346,896 $8.18 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $5.02 Million - $7.45 Million	274,045 Added 225.1%	395,789 $10.4 Million
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $1.38 Million - $1.99 Million	-97,108 Reduced 44.37%	121,744 $2.24 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $1.87 Million - $3.45 Million	-145,763 Reduced 39.98%	218,852 $3.39 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $52,229 - $81,061	2,802 Added 0.77%	364,615 $7.3 Million
Q2 2022 Oct 27, 2022	BUY	$13.98 - $29.25 $368,750 - $771,527	26,377 Added 7.86%	361,813 $8.19 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $368,750 - $771,527	26,377 Added 7.86%	361,813 $8.19 Million
Q1 2022 Oct 27, 2022	SELL	$23.58 - $30.91 $621,969 - $815,313	-26,377 Reduced 7.29%	335,436 $8.87 Million
Q1 2022 May 13, 2022	SELL	$23.58 - $30.91 $451,439 - $591,771	-19,145 Reduced 5.4%	335,436 $8.87 Million
Q4 2021 Feb 14, 2022	SELL	$20.0 - $32.29 $1.5 Million - $2.42 Million	-74,803 Reduced 17.42%	354,581 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $7.08 Million - $11.7 Million	429,384 New	429,384 $9.45 Million

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account